Short-Term Circulatory Support Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Short-Term Circulatory Support Devices Market Overview
The short-term circulatory support devices market size was valued at $1.62 billion in 2023. The market is expected to grow at a CAGR of more than 7% during 2023-2033. An increase in healthcare spending will drive the market growth during 2023-2033. Short-term circulatory support devices are used in patients with refractory cardiogenic shock as a bridge to a decision if unresponsive to the first-line therapy.
Short-Term Circulatory Support Devices Market Outlook, 2023-2033 ($ Billion)
Buy the Full Report for More Insights into the Short-Term Circulatory Support Devices Market Forecast
The short-term circulatory support devices market research report identifies quantitative market trends within cardiovascular devicestherapeutic areas. The report offers regional quantitative and qualitative data highlighting the sales in major markets. The model also covers in detail the effects of COVID-19 on the short-term circulatory support devices market for 2020 and beyond. Furthermore, the report provides short-term circulatory support devices market share by company that will help in identifying untapped market opportunities.
Market Size (2023) | $1.62 Billion |
CAGR (2023-2033) | >7% |
Forecast Period | 2023-2033 |
Historical Period | 2015-2022 |
Key Regions | · North America
· Europe · Asia Pacific · South Central America · Middle East and Africa |
Key Segments | · Percutaneous Ventricular Assist Devices
· Intra-Aortic Balloon Pump Catheters · Short-Term External/Paracorporeal Ventricular Assist Devices |
Leading Companies | · Johnson & Johnson
· Getinge AB · Abbott Laboratories · LivaNova Plc · Teleflex Inc |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Short-Term Circulatory Support Devices Market Segments
The key segments in the Short-Term Circulatory Support Devices market are Percutaneous Ventricular Assist Devices, Intra-Aortic Balloon Pump Catheters, and Short-Term External/Paracorporeal Ventricular Assist Devices. The Percutaneous Ventricular Assist Devices segment led the market in 2023.
A Percutaneous Ventricular Assist Device (PVAD) is a catheter-based pump placed into the heart to help improve cardiac output to meet the oxygen demand of the body. This device utilizes a minimally invasive approach for insertion.
Intra-Aortic Balloon Pumps require the use of Intra-Aortic Balloon Pump Catheters. These catheters help improve the body’s cardiac output when used with Intra-Aortic Balloon Pumps. Intra-aortic balloon Pump Catheters assist in meeting the oxygen demand of the body. One unit refers to one Intra-Aortic Balloon Pump Catheter.
Short-Term Circulatory Support Devices Market Analysis, by Segments 2023 (%)
Buy the Full Report for More Segment-Wise Insights into the Short-Term Circulatory Support Devices Market,
Short-Term Circulatory Support Devices Market – Competitive Landscape
In 2023, Johnson & Johnson short-term circulatory support devices market share dominated the market.
The major leading companies in the Short-Term Circulatory Support Devices market are:
- Johnson & Johnson
- Getinge AB
- Abbott Laboratories
- LivaNova Plc
- Teleflex Inc
Short-Term Circulatory Support Devices Market Analysis, by Companies 2023 (%)
Buy the Full Report for More Insights into the Companies in Short-Term Circulatory Support Devices Market
Regional Analysis of Short-Term Circulatory Support Devices Market
The key regions in the short-term circulatory support devices market are North America, Europe, Asia Pacific, South America, and the Middle East & Africa. In 2023, North America dominated the global Short-term circulatory support devices market and will continue to do so during the forecast period, due to the large patient pool in the region. The US, Canada, and Mexico are the key countries in the region.
The US short-term circulatory support devices market follows global and regional trends for North America. Factors such as unhealthy lifestyles, the rapid growth of population, increase in number of surgical procedures, and rise in health care expenditure will influence the Short-Term Circulatory Support Devices market positively during the projected period.
Short-Term Circulatory Support Devices Market Analysis, by Regions 2023 (%)
Buy the Full Report for More Regional Insights in the Short-Term Circulatory Support Devices Market,
Short-Term Circulatory Support Devices Market Dynamics
Trends: The short-term circulatory support devices market will experience steady growth in the forecast period owing to the increasing burden of CVD diseases and the rising geriatric population. Furthermore, North America (particularly the US and Canada) and major European countries will continue experiencing growth due to strong healthcare infrastructure, trained specialists, and healthcare resources.
Future Outlook: A few developing countries in Asia Pacific, South Central America, and Middle East, and Africa are likely to become saturated. This is primarily due to the lack of proper healthcare infrastructure in these regions. Socioeconomic factors limited medical procedure reimbursement, and inadequate insurance coverage also contribute to this issue.
Segments Covered in the Report
Short-Term Circulatory Support Devices Segments Outlook (Value, $ Billion, 2015-2033)
- Percutaneous Ventricular Assist Devices
- Intra-Aortic Balloon Pump Catheters
- Short-Term External/Paracorporeal Ventricular Assist Devices
Short-Term Circulatory Support Devices Regional Outlook (Value, $ Billion, 2015-2033)
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
Key Inclusions
The short-term circulatory support devices market research report includes an insightful review of the key industry trends.
- The short-term circulatory support devices market report offers an annualized market revenue by segment and market outlooks from 2015-2033.
- The report also includes market-level data on units, average selling prices, and market values.
Regional, country, and global short-term circulatory support devices market insights:
- The short-term circulatory support devices market share report offers qualitative insights on global and regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- Short-term circulatory support devices market SWOT analysis.
- The report provides trends and short-term circulatory support devices market competitive dynamics.
Buy the Full Report for More Insights on the Short-Term Circulatory Support Devices Market Share, Download a Free Sample Report
Learn about consumer behavior through the detailed overview of segments and the healthcare system. The report also offers information on reimbursement policies and the regulatory landscape.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. These syndicated models include demand and supply-side primary sources including Key opinion leaders. Furthermore, determine market trends through real-world data sources including databases of government procedures and hospital purchasing.
Companies covered: Abiomed Inc., LivaNova Plc, Getinge AB, Abbott Laboratories, Teleflex Inc., Zeon Medical Inc, Senko Medical Instrument Manufacturing Co Ltd, Berlin Heart GmbH, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
- Extensive coverage of the short-term circulatory support devices market under development.
- An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
- Reviews of major players involved in the development of the short-term circulatory support devices market and lists all their pipeline projects.
- Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
- Key clinical trial data of ongoing clinical trials specific to pipeline products.
- Recent developments in the segment/industry.
Reasons to Buy
- Understand the COVID-19 impact on short-term circulatory support devices.
- Design your licensing strategies through a review of products, technologies, and companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving short-term circulatory support devices.
- Understand the trends, innovative product launches, technologies, segments, and companies that will impact the market in the future.
- Formulate effective sales and marketing strategies with a detailed evaluation of short-term circulatory support devices market share by company. Identify strong competitors and create winning strategies to stand out in the global short-term circulatory support devices market.
- Track regional short-term circulatory support devices market sales as well as country-specific transactions from 2015-2033.
- Organize your sales and marketing efforts by identifying the global short-term circulatory support devices market segments that present maximum opportunities. Such details will help to make investments and strategic partnerships.
LivaNova Plc
Getinge AB
Abbott Laboratories
Teleflex Inc
Zeon Medical Inc
Senko Medical Instrument Manufacturing Co Ltd
Berlin Heart GmbH
Others
Frequently asked questions
-
What was the Short-Term Circulatory Support Devices market size in 2023?
The Short-Term Circulatory Support Devices market size was $1.62 billion in 2023.
-
What will the Short-Term Circulatory Support Devices market growth rate be during the forecast period?
The Short-Term Circulatory Support Devices market will grow at a CAGR of more than 7% during 2023-2033.
-
Which region dominated the Short-Term Circulatory Support Devices market in 2023?
North America dominated the overall Short-Term Circulatory Support Devices market in 2023.
-
Which segment led the Short-Term Circulatory Support Devices market in 2023?
The Percutaneous Ventricular Assist Devices segment led the market in 2023.
-
Which are the leading companies in the Short-Term Circulatory Support Devices market?
A few of the leading companies in the Short-Term Circulatory Support Devices market are Johnson & Johnson, Getinge AB, Abbott Laboratories, LivaNova Plc, and Teleflex Inc among Others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.